Tandem Diabetes Care Inc
TNDM21.700USD
-0.800-3.56%
Cierre 01/09, 16:00（ET）Cotizaciones retrasadas 15 min
1.47BCap. mercado
PérdidaP/E TTM
Más Datos de Tandem Diabetes Care Inc Compañía
Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company that manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in the targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of its AID systems, it offers pump integration with multiple CGM sensors.
Información de Tandem Diabetes Care Inc
Símbolo de cotizaciónTNDM
Nombre de la empresaTandem Diabetes Care Inc
Fecha de salida a bolsaNov 13, 2013
Director ejecutivoSheridan (John F)
Número de empleados2650
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 13
Dirección12400 High Bluff Drive
CiudadSAN DIEGO
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal92130
Teléfono18583666900
Sitio Webhttps://www.tandemdiabetes.com/
Símbolo de cotizaciónTNDM
Fecha de salida a bolsaNov 13, 2013
Director ejecutivoSheridan (John F)
Ejecutivos de Tandem Diabetes Care Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. John F. Sheridan
Mr. John F. Sheridan
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
117.60K
+5637.00%
Ms. Leigh A. Vosseller
Ms. Leigh A. Vosseller
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
49.51K
+1925.00%
Ms. Susan M. Morrison
Ms. Susan M. Morrison
Executive Vice President, Chief Administrative Officer
Executive Vice President, Chief Administrative Officer
40.92K
+1855.00%
Mr. Mark David Novara
Mr. Mark David Novara
Executive Vice President and Chief Commercial Officer
Executive Vice President and Chief Commercial Officer
35.96K
+3572.00%
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
28.36K
+4387.00%
Mr. Rick Carpenter
Mr. Rick Carpenter
Chief Technical Officer
Chief Technical Officer
24.25K
+199.00%
Mr. Jean-Claude (JC) Kyrillos
Mr. Jean-Claude (JC) Kyrillos
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
22.54K
+160.00%
Dr. Kathleen McGroddy-Goetz, Ph.D.
Dr. Kathleen McGroddy-Goetz, Ph.D.
Independent Director
Independent Director
17.85K
+4387.00%
Ms. Rebecca B. (Beckie) Robertson
Ms. Rebecca B. (Beckie) Robertson
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Elizabeth A. Gasser
Ms. Elizabeth A. Gasser
Executive Vice President and Chief Strategy and Product Officer
Executive Vice President and Chief Strategy and Product Officer
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. John F. Sheridan
Mr. John F. Sheridan
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
117.60K
+5637.00%
Ms. Leigh A. Vosseller
Ms. Leigh A. Vosseller
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
49.51K
+1925.00%
Ms. Susan M. Morrison
Ms. Susan M. Morrison
Executive Vice President, Chief Administrative Officer
Executive Vice President, Chief Administrative Officer
40.92K
+1855.00%
Mr. Mark David Novara
Mr. Mark David Novara
Executive Vice President and Chief Commercial Officer
Executive Vice President and Chief Commercial Officer
35.96K
+3572.00%
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
28.36K
+4387.00%
Mr. Rick Carpenter
Mr. Rick Carpenter
Chief Technical Officer
Chief Technical Officer
24.25K
+199.00%
Desglose de ingresos
Divisa: USDActualizado: mar., 6 de ene
Divisa: USDActualizado: mar., 6 de ene
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Pump
110.11M
44.18%
Supplies and other - Domestic
90.85M
36.45%
Supplies and other-International
48.29M
19.38%
Por regiónUSD
Nombre
Ganancia
Proporción
Domestic
84.78M
34.02%
International
25.33M
10.16%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Pump
110.11M
44.18%
Supplies and other - Domestic
90.85M
36.45%
Supplies and other-International
48.29M
19.38%
Estadísticas de accionistas
Actualizado: hace 22 horas
Actualizado: hace 22 horas
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
14.97%
The Vanguard Group, Inc.
10.40%
Sessa Capital
7.37%
ArrowMark Colorado Holdings, LLC
5.44%
GW&K Investment Management, LLC
4.01%
Otro
57.80%
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
14.97%
The Vanguard Group, Inc.
10.40%
Sessa Capital
7.37%
ArrowMark Colorado Holdings, LLC
5.44%
GW&K Investment Management, LLC
4.01%
Otro
57.80%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
56.02%
Investment Advisor/Hedge Fund
31.50%
Hedge Fund
20.88%
Research Firm
5.08%
Pension Fund
1.32%
Individual Investor
1.08%
Bank and Trust
0.93%
Venture Capital
0.11%
Family Office
0.07%
Participación institucional
Actualizado: jue., 1 de ene
Actualizado: jue., 1 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
652
79.08M
116.63%
-22.41M
2025Q3
659
81.42M
120.08%
-12.14M
2025Q2
684
76.82M
113.72%
-10.68M
2025Q1
717
75.41M
113.22%
-13.00M
2024Q4
729
74.63M
112.27%
-13.07M
2024Q3
730
75.54M
115.38%
-14.87M
2024Q2
754
76.14M
117.84%
-16.88M
2024Q1
762
76.49M
116.55%
-10.19M
2023Q4
800
72.80M
111.65%
-12.99M
2023Q3
790
71.79M
110.32%
-10.32M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
BlackRock Institutional Trust Company, N.A.
10.15M
14.97%
+556.59K
+5.80%
Sep 30, 2025
The Vanguard Group, Inc.
7.05M
10.4%
-306.52K
-4.17%
Sep 30, 2025
Sessa Capital
5.00M
7.37%
--
--
Sep 30, 2025
ArrowMark Colorado Holdings, LLC
3.69M
5.44%
+991.65K
+36.73%
Sep 30, 2025
GW&K Investment Management, LLC
2.72M
4.01%
-168.48K
-5.83%
Sep 30, 2025
State Street Investment Management (US)
2.67M
3.94%
+22.30K
+0.84%
Sep 30, 2025
Hood River Capital Management LLC
2.55M
3.76%
-13.33K
-0.52%
Sep 30, 2025
Paradice Investment Management LLC
2.20M
3.24%
+429.29K
+24.29%
Sep 30, 2025
Two Sigma Investments, LP
2.09M
3.08%
-32.73K
-1.54%
Sep 30, 2025
Freestone Grove Partners LP
1.87M
2.76%
+1.87M
--
Sep 30, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
State Street SPDR S&P Health Care Equipment ETF
2.02%
Global X HealthTech ETF
1.14%
Invesco NASDAQ Future Gen 200 ETF
0.6%
Invesco S&P SmallCap Health Care ETF
0.58%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.38%
Inspire Small/Mid Cap ESG ETF
0.36%
Langar Global HealthTech ETF
0.35%
iShares S&P Small-Cap 600 Growth ETF
0.18%
Fidelity Enhanced Small Cap ETF
0.14%
State Street SPDR S&P 600 Small Cap Growth ETF
0.13%
Ver más
State Street SPDR S&P Health Care Equipment ETF
Proporción2.02%
Global X HealthTech ETF
Proporción1.14%
Invesco NASDAQ Future Gen 200 ETF
Proporción0.6%
Invesco S&P SmallCap Health Care ETF
Proporción0.58%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proporción0.38%
Inspire Small/Mid Cap ESG ETF
Proporción0.36%
Langar Global HealthTech ETF
Proporción0.35%
iShares S&P Small-Cap 600 Growth ETF
Proporción0.18%
Fidelity Enhanced Small Cap ETF
Proporción0.14%
State Street SPDR S&P 600 Small Cap Growth ETF
Proporción0.13%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Tandem Diabetes Care Inc?
Los cinco principales accionistas de Tandem Diabetes Care Inc son:
BlackRock Institutional Trust Company, N.A. posee 10.15M acciones, lo que representa el 14.97% del total de acciones.
The Vanguard Group, Inc. posee 7.05M acciones, lo que representa el 10.40% del total de acciones.
Sessa Capital posee 5.00M acciones, lo que representa el 7.37% del total de acciones.
ArrowMark Colorado Holdings, LLC posee 3.69M acciones, lo que representa el 5.44% del total de acciones.
GW&K Investment Management, LLC posee 2.72M acciones, lo que representa el 4.01% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 10.15M acciones, lo que representa el 14.97% del total de acciones.
The Vanguard Group, Inc. posee 7.05M acciones, lo que representa el 10.40% del total de acciones.
Sessa Capital posee 5.00M acciones, lo que representa el 7.37% del total de acciones.
ArrowMark Colorado Holdings, LLC posee 3.69M acciones, lo que representa el 5.44% del total de acciones.
GW&K Investment Management, LLC posee 2.72M acciones, lo que representa el 4.01% del total de acciones.
¿Cuáles son los tres principales tipos de accionista de Tandem Diabetes Care Inc?
Los tres principales tipos de accionista de Tandem Diabetes Care Inc son:
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Sessa Capital
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Sessa Capital
¿Cuántas instituciones poseen acciones de Tandem Diabetes Care Inc (TNDM)?
A fecha de 2025Q4, 652 instituciones poseen acciones de Tandem Diabetes Care Inc, con un valor de mercado combinado de aproximadamente 79.08M, lo que representa el 116.63% del total de acciones. En comparación con el 2025Q3, el accionariado institucional ha aumentado en -3.45%.
¿Cuál es la mayor fuente de ganancias de Tandem Diabetes Care Inc?
El FY2025Q3, el segmento empresarial Pump generó la ganancia más alta para Tandem Diabetes Care Inc, ascendiendo a 110.11M y representando el 44.18% de la ganancia total.
